Courtney Camp Enloe's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 2,740 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2025 | 2,740 | 2,740 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2025 | 768 | 903 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2025 | 768 | 2,304 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 295.43 per share. | 05 Sep 2025 | 275 | 628 (0%) | 0% | 295.4 | 81,243 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2025 | 186 | 196 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2025 | 186 | 558 | - | - | Restricted Stock Units | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.75 per share. | 24 Apr 2025 | 67 | 129 (0%) | 0% | 249.7 | 16,733 | Bio-Rad A Common Stock |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 1,946 | 1,946 | - | - | Non-Qualified Stock Option (right to buy) | |
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | 06 Sep 2024 | 3,072 | 3,072 | - | - | Restricted Stock Units | ||
| BioRad Laboratories Inc | Courtney Camp Enloe | EVP, General Counsel & Sec | 24 Apr 2024 | 744 | 744 | - | - | Restricted Stock Units |